PRTC — Puretech Health Income Statement
0.000.00%
Last trade - 00:00
- £557.45m
- £289.61m
- $15.62m
- 29
- 11
- 90
- 36
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20.7 | 9.81 | 11.8 | 17.4 | 15.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 114 | -522 | 131 | 168 | 166 |
Operating Profit | -93.5 | 532 | -120 | -150 | -151 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -68.4 | 478 | 19 | -59 | -92.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -70.7 | 366 | 4.57 | -62.7 | -37.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -43.7 | 421 | 5.99 | -60.6 | -50.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -43.7 | 421 | 5.99 | -60.6 | -50.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.194 | -0.044 | 0.021 | -0.211 | -0.281 |